We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHK icon
726
Mohawk Industries
MHK
$6.9B
$379K ﹤0.01%
2,779
-657
-19% -$89.4K
TSN icon
727
Tyson Foods
TSN
$20.2B
$360K ﹤0.01%
+3,959
New +$340K
PKX icon
728
POSCO
PKX
$15.8B
$355K ﹤0.01%
7,020
-6,899
-50% -$332K
UDR icon
729
UDR
UDR
$12.9B
$352K ﹤0.01%
7,538
+3,339
+80% +$160K
AMX icon
730
America Movil
AMX
$78.1B
$345K ﹤0.01%
21,550
+8,814
+69% +$138K
TER icon
731
Teradyne
TER
$54.8B
$345K ﹤0.01%
5,063
-48,228
-90% -$3.06M
QSR icon
732
Restaurant Brands International
QSR
$25.1B
$326K ﹤0.01%
5,110
+11
+0.2% +$736
CX icon
733
Cemex
CX
$17.4B
$318K ﹤0.01%
84,075
-60,300
-42% -$230K
XBI icon
734
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$298K ﹤0.01%
3,130
COO icon
735
Cooper Companies
COO
$13.7B
$294K ﹤0.01%
3,664
+496
+16% +$37.4K
CVE icon
736
Cenovus Energy
CVE
$54.6B
$293K ﹤0.01%
28,821
-5,643
-16% -$51.2K
PKG icon
737
Packaging Corp of America
PKG
$22.7B
$283K ﹤0.01%
+2,531
New +$279K
EMQQ icon
738
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$258M
$282K ﹤0.01%
7,960
+1,500
+23% +$49.8K
LEG icon
739
Leggett & Platt
LEG
$1.52B
$278K ﹤0.01%
5,468
+79
+1% +$3.87K
CIG icon
740
CEMIG Preferred Shares
CIG
$6.09B
$258K ﹤0.01%
148,161
+39,022
+36% +$63.7K
YELL
741
DELISTED
Yellow Corporation Common Stock
YELL
$258K ﹤0.01%
101,000
VICI icon
742
VICI Properties
VICI
$29.4B
$252K ﹤0.01%
+9,873
New +$239K
RGLD icon
743
Royal Gold
RGLD
$17.1B
$237K ﹤0.01%
+1,935
New +$229K
DRE
744
DELISTED
Duke Realty Corp.
DRE
$237K ﹤0.01%
+6,822
New +$236K
WB icon
745
Weibo
WB
$1.9B
$232K ﹤0.01%
5,000
-5,000
-50% -$234K
AXTA icon
746
Axalta
AXTA
$7.01B
$220K ﹤0.01%
+7,227
New +$213K
KRC icon
747
Kilroy Realty
KRC
$4.58B
$217K ﹤0.01%
+2,582
New +$211K
LTM
748
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$217K ﹤0.01%
21,347
+3,625
+20% +$40.5K
HUBS icon
749
HubSpot
HUBS
$10.5B
$203K ﹤0.01%
+1,280
New +$196K
EV
750
DELISTED
Eaton Vance Corp.
EV
$203K ﹤0.01%
+4,349
New +$201K

Similar funds

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.